Dot1L Inhibitor 13

SL-2675

Dot1L Inhibitor 13, >98% (HPLC)

CAS No. : [1940206-71-2]

IUPAC Name : N4-Methyl-N2-(2-methyl-1-(2-((3-methyl-3H-imidazo[4,5-b]pyridin-6-yl)oxy)phenyl)-1H-indol-6-yl)pyrimidine-2,4-diamine

Price And Availability
Pack Size	Price in USD	Add To Shopping Cart	Availability	Shipping Status
5MG	Request A Quote		Back Order	Estimated to ship on 01 November 2026
10MG	Request A Quote		Back Order	Estimated to ship on 01 November 2026
25MG	Request A Quote		Back Order	Estimated to ship on 01 November 2026
50MG	Request A Quote		Back Order	Estimated to ship on 01 November 2026
100MG	Request A Quote		Back Order	Estimated to ship on 01 November 2026
250MG	Request A Quote		Back Order	Estimated to ship on 01 November 2026
500MG	Request A Quote		Back Order	Estimated to ship on 01 November 2026
Note: SL-2675 is not in stock but can be available through custom synthesis. The estimated lead-time is 8-10 weeks. The product will be characterized by NMR and Mass analysis. Purity (HPLC) is usually >98%. COA, QC data and SDS will be provided along with the product. For information on pricing and availability please contact us at sales@syninnova.com or Request A Quote. We respond promptly. Thank You!

Applications : SL-2675 is a potent, selective and orally bioavailable inhibitor of Dot1L with an IC₅₀ and Ki of 0.4 nM and 0.08 nM, respectively.

References : Chen C. et al.: ACS Med. Chem. Lett., 7(8), 735-740, 2016.

Storage : Keep container tightly closed under nitrogen or argon and refrigerate for long-term shelf life.

Caution : In case of contact with skin or eyes, rinse immediately with plenty of water and seek medical advice. Wear suitable protective clothing and gloves.